Transdermal Analgesics for Chronic Musculoskeletal Pain Reviewed
Preliminary results suggest that transdermal analgesic is efficacious in reducing both opioid use and pain scores.
Preliminary results suggest that transdermal analgesic is efficacious in reducing both opioid use and pain scores.
Jeffrey Gudin, MD, recommends a “stepwise approach” to designing a treatment plan for patients with chronic pain.
Pain catastrophizing was significantly reduced by this simple 2-hour psycho-educational class.
Several imminent pain pharmacotherapy patent expirations are forecasted to affect the pain management landscape.
The model proposes that prioritizing alternate life goals with optimism rather than perpetuating pain-associated behaviors with negative affect can break the pain cycle.
Among older adults, immune system dysregulation may contribute to the increased prevalence of pain in older adults
This study should help identify CSM patients at higher risks of developing perioperative complications, and to anticipate these by taking preventive measures, and closely monitoring patients
Investigators hypothesized that fibroblast-like synoviocytes, which line joints had variable epigenetic patterns, underlying variations in joint inflammation and response to treatment.
Stem cells isolated from bone marrow have been shown to efficiently support repair of injured ligaments and tendons and adipose stem cells have some benefits for cartilage repair.
Therapeutic anti-TNF antibodies, long thought to act primarily via blockade of proinflammatory soluble TNF, appear to also bind membrane-bound TNF supporting regulatory T-cell expansion suppressing further inflammation.